Inhibition and induction of CYP enzymes in humans: an update
The cytochrome P450 (CYP) enzyme family is the most important enzyme system catalyzing
the phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies …
the phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies …
Resveratrol and its human metabolites—effects on metabolic health and obesity
M Springer, S Moco - Nutrients, 2019 - mdpi.com
Resveratrol is one of the most widely studied polyphenols and it has been assigned a
plethora of metabolic effects with potential health benefits. Given its low bioavailability and …
plethora of metabolic effects with potential health benefits. Given its low bioavailability and …
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
M Martignoni, GMM Groothuis… - Expert opinion on drug …, 2006 - Taylor & Francis
Animal models are commonly used in the preclinical development of new drugs to predict
the metabolic behaviour of new compounds in humans. It is, however, important to realise …
the metabolic behaviour of new compounds in humans. It is, however, important to realise …
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
G Milano, F Innocenti, H Minami - Cancer Science, 2022 - Wiley Online Library
Irinotecan is a topoisomerase inhibitor, widely used in treatment of malignancies including
pancreatic ductal adenocarcinoma (PDAC) as part of the FOLFIRINOX regimen prescribed …
pancreatic ductal adenocarcinoma (PDAC) as part of the FOLFIRINOX regimen prescribed …
Caffeine consumption through coffee: Content in the beverage, metabolism, health benefits and risks
J dePaula, A Farah - Beverages, 2019 - mdpi.com
Caffeine (1, 3, 7-trimethylxanthine) is the most consumed psychoactive substance in the
world, acting by means of antagonism to adenosine receptors, mainly A1 and A2A. Coffee is …
world, acting by means of antagonism to adenosine receptors, mainly A1 and A2A. Coffee is …
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
The aim of this review is to analyse critically the recent literature on the clinical
pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplant recipients …
pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplant recipients …
Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
D Wang, Y Guo, SA Wrighton, GE Cooke… - The pharmacogenomics …, 2011 - nature.com
Abstract Cytochrome P450 3A4 (CYP3A4) metabolizes∼ 50% of all clinically used drugs.
Although CYP3A4 expression varies widely between individuals, the contribution of genetic …
Although CYP3A4 expression varies widely between individuals, the contribution of genetic …
Mechanisms of drug resistance in cancer chemotherapy
YA Luqmani - Medical principles and practice, 2005 - karger.com
The management of cancer involves procedures, which include surgery, radiotherapy and
chemotherapy. Development of chemoresistance is a persistent problem during the …
chemotherapy. Development of chemoresistance is a persistent problem during the …
Resveratrol'biotechnological applications: Enlightening its antimicrobial and antioxidant properties
J Sharifi-Rad, C Quispe, A Durazzo, M Lucarini… - Journal of Herbal …, 2022 - Elsevier
Abstract Introduction Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene) is a polyphenol obtained
from diverse groups of plants, especially in the muscadine grape, red wine, lingonberry …
from diverse groups of plants, especially in the muscadine grape, red wine, lingonberry …
Maraviroc: a review of its use in HIV infection and beyond
SM Woollard, GD Kanmogne - Drug design, development and …, 2015 - Taylor & Francis
The human immunodeficiency virus-1 (HIV-1) enters target cells by binding its envelope
glycoprotein gp120 to the CD4 receptor and/or coreceptors such as CC chemokine receptor …
glycoprotein gp120 to the CD4 receptor and/or coreceptors such as CC chemokine receptor …